Nephrogenic systemic fibrosis associated with gadolinium based contrast agents: a summary of the medical literature reporting.
about
Nephrogenic systemic fibrosis: a survey of nephrologists' perceptions and practices.Magnetic particle imaging (MPI) for NMR and MRI researchersGadolinium contrast agent-induced CD163+ ferroportin+ osteogenic cells in nephrogenic systemic fibrosisPhysicochemical characterization of a novel graphene-based magnetic resonance imaging contrast agentManganese(III) porphyrins complexed with P22 virus-like particles as T1-enhanced contrast agents for magnetic resonance imaging.MR imaging of high-grade brain tumors using endogenous protein and peptide-based contrast.Arterial spin labeling characterization of cerebral perfusion during normal maturation from late childhood into adulthood: normal 'reference range' values and their use in clinical studiesNephrogenic systemic fibrosis in liver disease: a systematic review.Potential of computer-aided diagnosis of high spectral and spatial resolution (HiSS) MRI in the classification of breast lesionsQuantitative renal perfusion measurements in a rat model of acute kidney injury at 3T: testing inter- and intramethodical significance of ASL and DCE-MRIA two-stage model for in vivo assessment of brain tumor perfusion and abnormal vascular structure using arterial spin labeling.Responses of human skin in organ culture and human skin fibroblasts to a gadolinium-based MRI contrast agent: comparison of skin from patients with end-stage renal disease and skin from healthy subjects.An Updated Study to Determine Association between Gadolinium-Based Contrast Agents and Nephrogenic Systemic Fibrosis.Stimulation of fibroblast proliferation by insoluble gadolinium salts.Contrast-induced acute kidney injury and diabetic nephropathy.The effect of contrast medium SonoVue® on the electric charge density of blood cells.Gadolinium free cardiovascular magnetic resonance with 2-point Cine balanced steady state free precession.Nephrogenic systemic fibrosis: risk factors suggested from Japanese published cases.Challenges in RCC Imaging: Renal Insufficiency, Post-Operative Surveillance, and the Role of Radiomics.Non-Contrast Renal MR Angiography: Value of Subtraction of Tagging and Non-Tagging Technique.Decreased incidence of NSF in patients on dialysis after changing gadolinium contrast-enhanced MRI protocols.Functional immunoassay technology (FIT), a new approach for measuring physiological functions: application of FIT to measure glomerular filtration rate (GFR).Antiangiogenic synergism of integrin-targeted fumagillin nanoparticles and atorvastatin in atherosclerosisAccuracy of unenhanced magnetic resonance angiography for the assessment of renal artery stenosis.Gadolinium-based contrast agents and nephrogenic systemic fibrosis: a systematic review and meta-analysis.Cutaneous manifestations of ESRD.The synthesis and application of polyamino polycarboxylic bifunctional chelating agents.Nephrogenic systemic fibrosis: review of 408 biopsy-confirmed casesUpdate on nephrogenic systemic fibrosis: are we making progress?Nephrogenic systemic fibrosis and gadolinium-based contrast media: updated ESUR Contrast Medium Safety Committee guidelines.Superior vena cava stenting guided by alternative imaging modalities in a patient with severe contrast allergy: a case report and brief literature review.Gadolinium-Based Contrast Agent Accumulation and Toxicity: An Update.Imaging patients with renal impairment.3D morphometry using automated aortic segmentation in native MR angiography: an alternative to contrast enhanced MRA?Low detection rate of craniocervical arterial dissection in children using time-of-flight magnetic resonance angiography: causes and strategies to improve diagnosis.3D FIESTA pulse sequence for assessing renal artery stenosis: is it a reliable application in unenhanced magnetic resonance angiography?Understanding nephrogenic systemic fibrosisInduction of the expression of profibrotic cytokines and growth factors in normal human peripheral blood monocytes by gadolinium contrast agentsHyperphosphataemia sensitizes renally impaired rats to the profibrotic effects of gadodiamideGadolinium-induced oxidative stress triggers endoplasmic reticulum stress in rat cortical neurons.
P2860
Q24602293-16045A3D-4671-4B56-9312-38B73D6A6507Q26827983-702F6F87-70E8-409A-859B-C7C460A9B575Q30410917-4537A7C9-D649-4362-AABD-A03B2AE78EC9Q30661518-4A20DECB-1408-41F4-91D6-246F5D6B5BB9Q30722696-AFB48E23-850D-48A7-8B99-F3F62465F9A3Q33534946-CA8CCEF1-E273-489D-9074-24117FBFA039Q33581143-70DAA79B-05A3-4106-8447-19E41CCC84B2Q33748364-595EED08-C87E-4DA4-A66D-271877468BB3Q34084804-8A731C2C-CD6F-48F4-9907-BBEB2EFE8091Q34545415-BD69993F-33F9-4C5A-804B-0241630024FEQ35009151-F271AAB1-BDAF-4391-B8E4-7805833B675DQ35187986-BDE77D9F-C17E-45F1-B6B5-9252EE6C410CQ35664137-C3E29C2E-90A7-4212-9BED-F002561644F6Q35740116-C0813C40-ED6D-4011-A586-75487B853325Q35766187-0AE8D881-1082-4E84-8B4E-49EE07B1CF40Q35775581-778BA078-385A-40FD-85BC-0E82D2D5121BQ36235217-0D329324-A266-4C6F-B506-B7067ADE6081Q36324674-1A7886F5-D707-4B7A-877D-0178D6321DF4Q36628918-13A1B004-7351-4F45-996A-7E6304BF0CE2Q36679513-0997BFDD-0449-49A2-9E6F-AF4D772F668CQ36974375-C299D1B6-29B1-44F5-B4D1-DA39AE66A885Q36977447-72910729-A666-467B-8777-11A5288B978BQ37085672-898195C0-8A41-4A0E-9CBB-543FF7B02834Q37156023-D4F429DB-0EC7-47F5-A22E-46C745FC1C9EQ37308825-826E1BFF-3CCC-416D-90B1-4554D7B334D2Q37426978-04214FD5-1F6A-4158-B5B0-18230F8508A6Q37850696-88657A20-8128-45BC-80F4-6E6B90B6A6DEQ37875688-915D4388-04A2-4000-8F0E-96A8FDE080D4Q37877286-F52ED9FC-366F-4FB9-87C5-AA6FE9E39370Q38032230-17DE2064-F0AE-4CC1-A0CE-B82BE9B8EA33Q38117763-A07160F3-539F-46B3-BB03-59920A7ACE08Q38667169-BF4056FA-FD90-464E-A81E-4B3080FB47ADQ38789239-92DFCA19-F84D-4FA1-8971-9ED4F3076B81Q38907547-D43B5BF2-C17C-4123-9F4D-D2C885C807D6Q39880434-33B5C1EB-9D9E-439F-81B4-28068091A494Q40210085-67167486-0771-4D56-8DB0-41AA4FE4D88FQ41545279-1E34173B-D773-4548-A577-A24B359EC68DQ42061581-1D240800-2442-4BB3-90C4-3A98019E9320Q42135667-698635EF-63E3-4D3E-89E8-13A8BE617923Q42768469-2FEA981E-FFBF-4DB8-A15E-D698DC90FBBD
P2860
Nephrogenic systemic fibrosis associated with gadolinium based contrast agents: a summary of the medical literature reporting.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 26 March 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Nephrogenic systemic fibrosis ...... medical literature reporting.
@en
Nephrogenic systemic fibrosis ...... medical literature reporting.
@nl
type
label
Nephrogenic systemic fibrosis ...... medical literature reporting.
@en
Nephrogenic systemic fibrosis ...... medical literature reporting.
@nl
prefLabel
Nephrogenic systemic fibrosis ...... medical literature reporting.
@en
Nephrogenic systemic fibrosis ...... medical literature reporting.
@nl
P1476
Nephrogenic systemic fibrosis ...... medical literature reporting.
@en
P2093
Dale R Broome
P304
P356
10.1016/J.EJRAD.2008.02.011
P577
2008-03-26T00:00:00Z